Targeting the dynamic HSP90 complex in cancer (Q28288602)

title

Targeting the dynamic HSP90 complex in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

4

Len Neckers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

1

Jane Trepel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

author name string

Mehdi Mollapour

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

language of work or name

English

0 references

publication date

August 2010

0 references

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

page(s)

537-549

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

The Hsp90 chaperone machinery

12 May 2020

cites work

1 reference

Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone

31 March 2020

1 reference

Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery

31 March 2020

1 reference

HSP90 and the chaperoning of cancer

31 March 2020

1 reference

HSP90: the Rosetta stone for cellular protein dynamics?

31 March 2020

1 reference

The Hsp90 chaperone machinery regulates signaling by modulating ligand binding clefts

31 March 2020

1 reference

Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches.

31 March 2020

1 reference

Novel Hsp90 partners discovered using complementary proteomic approaches

31 March 2020

1 reference

Disassembly of transcriptional regulatory complexes by molecular chaperones

31 March 2020

1 reference

Hsp90: a chaperone for protein folding and gene regulation

31 March 2020

1 reference

Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression

31 March 2020

1 reference

NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis

31 March 2020

1 reference

Update on Hsp90 inhibitors in clinical trial.

31 March 2020

1 reference

Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress

31 March 2020

1 reference

Structure and mechanism of the Hsp90 molecular chaperone machinery

31 March 2020

1 reference

Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket

31 March 2020

1 reference

Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex

31 March 2020

1 reference

Structure and functional relationships of Hsp90.

31 March 2020

1 reference

Dimerization of Hsp90 is required for in vivo function. Design and analysis of monomers and dimers

31 March 2020

1 reference

Structural studies on the co-chaperone Hop and its complexes with Hsp90.

31 March 2020

1 reference

Structure of an Hsp90-Cdc37-Cdk4 complex.

31 March 2020

1 reference

Species-dependent ensembles of conserved conformational states define the Hsp90 chaperone ATPase cycle

31 March 2020

1 reference

Independent ATPase activity of Hsp90 subunits creates a flexible assembly platform

31 March 2020

1 reference

Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery.

31 March 2020

1 reference

The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis

31 March 2020

1 reference

Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90.

31 March 2020

1 reference

Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1

31 March 2020

1 reference

p23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity

31 March 2020

1 reference

Asymmetric Activation of the Hsp90 Dimer by Its Cochaperone Aha1

31 March 2020

1 reference

Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis

31 March 2020

1 reference

Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37.

31 March 2020

1 reference

Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning

31 March 2020

1 reference

Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta

31 March 2020

1 reference

Chaperoning of glucocorticoid receptors

31 March 2020

2 references

31 March 2020

12 December 2020

FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.

1 reference

Structural and functional coupling of Hsp90- and Sgt1-centred multi-protein complexes

31 March 2020

1 reference

The Hsp90 chaperone controls the biogenesis of L7Ae RNPs through conserved machinery

31 March 2020

1 reference

Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.

31 March 2020

1 reference

Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue

31 March 2020

1 reference

Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells

31 March 2020

1 reference

Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin

31 March 2020

1 reference

Post-translational modification of heat-shock protein 90: impact on chaperone function

31 March 2020

1 reference

Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp60v-src tyrosine kinase

31 March 2020

1 reference

The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90

31 March 2020

1 reference

Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase.

31 March 2020

1 reference

Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias

31 March 2020

1 reference

Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma

31 March 2020

1 reference

Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery

31 March 2020

1 reference

Cdk1-dependent regulation of the mitotic inhibitor Wee1.

31 March 2020

1 reference

Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function

31 March 2020

1 reference

Cell polarity, Notch signaling and neurogenesis.

31 March 2020

1 reference

Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228

31 March 2020

1 reference

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

31 March 2020

1 reference

An acetylation site in the middle domain of Hsp90 regulates chaperone function

31 March 2020

1 reference

Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion

31 March 2020

1 reference

Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin.

31 March 2020

1 reference

S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities

31 March 2020

1 reference

Modeling signal propagation mechanisms and ligand-based conformational dynamics of the Hsp90 molecular chaperone full-length dimer

31 March 2020

1 reference

Hsp90 is regulated by a switch point in the C-terminal domain

31 March 2020

1 reference

Induction of nitric oxide synthase-dependent telomere shortening after functional inhibition of Hsp90 in human tumor cells

31 March 2020

1 reference

The hsp90 molecular chaperone modulates multiple telomerase activities

31 March 2020

1 reference

The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review

31 March 2020

1 reference

Minireview: nuclear receptors and breast cancer

31 March 2020

1 reference

Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility

31 March 2020

1 reference

Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1

31 March 2020

1 reference

Modulation of Hsf1 activity by novobiocin and geldanamycin.

31 March 2020

1 reference

Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis

31 March 2020

1 reference

Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors

31 March 2020

1 reference

Identification of inhibitors of HSF1 functional activity by high-content target-based screening

31 March 2020

1 reference

The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.

31 March 2020

1 reference

A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo

31 March 2020

1 reference

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas

31 March 2020

1 reference

The role of IRF1 and IRF2 transcription factors in leukaemogenesis.

31 March 2020

1 reference

Cooperative regulation of the interferon regulatory factor-1 tumor suppressor protein by core components of the molecular chaperone machinery

31 March 2020

1 reference

Molecular pathology of mixed-lineage leukemia.

31 March 2020

1 reference

Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes

31 March 2020

1 reference

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

31 March 2020

1 reference

Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma

31 March 2020

1 reference

The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase

31 March 2020

1 reference

The molecular chaperone Hsp90 regulates accumulation of DNA polymerase eta at replication stalling sites in UV-irradiated cells

31 March 2020

1 reference

Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons

31 March 2020

1 reference

Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila

31 March 2020

1 reference

Functional involvement of Tudor and dPRMT5 in the piRNA processing pathway in Drosophila germlines

31 March 2020

1 reference

A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer

31 March 2020

1 reference

Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone

31 March 2020

1 reference

Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity

31 March 2020

1 reference

Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.

31 March 2020

1 reference

V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors

31 March 2020

1 reference

Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin

31 March 2020

1 reference

Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin

31 March 2020

1 reference

Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition

31 March 2020

1 reference

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth

31 March 2020

1 reference

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

31 March 2020

1 reference

Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade

31 March 2020

1 reference

Antimyeloma activity of heat shock protein-90 inhibition.

31 March 2020

1 reference

Signalling molecules essential for neuronal survival and differentiation

31 March 2020

1 reference

Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation

31 March 2020

1 reference

90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.

31 March 2020

1 reference

Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones

31 March 2020

1 reference

A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.

31 March 2020

1 reference

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

31 March 2020

1 reference

HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy

31 March 2020

1 reference

Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia

31 March 2020

1 reference

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

31 March 2020

1 reference

FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML.

31 March 2020

1 reference

Heat shock protein 90: a potential therapeutic target in leukemic progenitor and stem cells harboring mutant BCR-ABL resistant to kinase inhibitors

31 March 2020

1 reference

New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check

31 March 2020

1 reference

Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells.

31 March 2020

1 reference

ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia

31 March 2020

1 reference

Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target

31 March 2020

1 reference

Heat shock protein 90 inhibition in lung cancer

31 March 2020

1 reference

Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance

31 March 2020

1 reference

Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies

31 March 2020

1 reference

Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.

31 March 2020

1 reference

Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors

31 March 2020

1 reference

Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts

31 March 2020

1 reference

Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90.

31 March 2020

1 reference

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

31 March 2020

1 reference

Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies

31 March 2020

1 reference

An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors

31 March 2020

1 reference

(89)Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

31 March 2020

1 reference

Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules

31 March 2020

1 reference

Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab

31 March 2020

1 reference

Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r

31 March 2020

1 reference

Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models

31 March 2020

1 reference

Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin

31 March 2020

1 reference

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90

31 March 2020

1 reference

Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition

31 March 2020

1 reference

Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells

31 March 2020

1 reference

Tanespimycin: the opportunities and challenges of targeting heat shock protein 90.

31 March 2020

1 reference

Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism

31 March 2020

1 reference

Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis

31 March 2020

1 reference

Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?

31 March 2020

1 reference

Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma

31 March 2020

1 reference

Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin

31 March 2020

1 reference

Structural basis of the radicicol resistance displayed by a fungal hsp90

31 March 2020

1 reference

Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cells

31 March 2020

1 reference

KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells

31 March 2020

1 reference

Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells

31 March 2020

1 reference

A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

31 March 2020

1 reference

Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol

31 March 2020

1 reference

HSP90 regulates cell survival via inositol hexakisphosphate kinase-2.

31 March 2020

1 reference

Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones

31 March 2020

1 reference

The ATPase cycle of the endoplasmic chaperone Grp94.

31 March 2020

1 reference

The ATPase cycle of the mitochondrial Hsp90 analog Trap1.

31 March 2020

1 reference

Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug Design

31 March 2020

1 reference

31 March 2020

1 reference

Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis.

31 March 2020

1 reference

Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90

31 March 2020

1 reference

Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer

31 March 2020

1 reference

PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1

31 March 2020

1 reference

Extracellular HSP90: conquering the cell surface

31 March 2020

1 reference

Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness

31 March 2020

1 reference

Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases

31 March 2020

1 reference

A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion

31 March 2020

1 reference

Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing

31 March 2020

1 reference

Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing

31 March 2020

1 reference

Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain

31 March 2020

1 reference

A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.

31 March 2020

1 reference

Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis

31 March 2020

1 reference

Heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin enhances EphA2+ tumor cell recognition by specific CD8+ T cells.

31 March 2020

1 reference

Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists

31 March 2020

1 reference

Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease

31 March 2020

1 reference

Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET

31 March 2020

1 reference

12 December 2020

Hsp90 phosphorylation, Wee1 and the cell cycle

1 reference

12 December 2020

Mice lacking HSP90beta fail to develop a placental labyrinth

1 reference

12 December 2020

Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II.

1 reference

12 December 2020

Heat shock protein 70 (hsp70) as an emerging drug target.

1 reference

12 December 2020

Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex

1 reference

12 December 2020

Purine-scaffold Hsp90 inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC2887

2 references

Consolidated OpenCitations Corpus – April 2017

304214

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

Dimensions Publication ID

12 May 2020

1006993157

0 references

Fatcat ID

release_cvqh7f6upje5xdbwv4x7zmjzva

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cvqh7f6upje5xdbwv4x7zmjzva

24 November 2022

mapped directly with Wikidata item

304214

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6778733&resulttype=core&format=json

12 May 2020

PubMed publication ID

20651736

2 references

Consolidated OpenCitations Corpus – April 2017

304214